NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19
Severe acute respiratory syndrome caused by coronavirus 2 emerged in Wuhan (China) in December 2019 and has severely challenged the human population. NK and T cells are involved in the progression of COVID-19 infection through the ability of NK cells to modulate T-cell responses, and by the stimulat...
Guardado en:
Autores principales: | Laura Bergantini, Miriana d'Alessandro, Paolo Cameli, Dalila Cavallaro, Sara Gangi, Behar Cekorja, Piersante Sestini, Elena Bargagli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/31df8d5065e14aaea97a56c64c233692 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PECULIARITIES OF NK CELLS DIFFERENTIATION: CD56dim AND CD56bright NK CELLS AT PREGNANCY AND IN NON-PREGNANT STATE
por: V. A. Mikhailova, et al.
Publicado: (2017) -
Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
por: Erica L. Heipertz, et al.
Publicado: (2021) -
EVALUATION OF MICROVESICLES FORMED BY NATURAL KILLER (NK) CELLS USING FLOW CYTOMETRY
por: V. A. Mikhailova, et al.
Publicado: (2018) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Sergey Kulemzin, et al.
Publicado: (2021) -
Challenging the Conventional Interpretation of HCMV Seronegativity
por: Shelley Waters, et al.
Publicado: (2021)